Acop, Riza Mae T.
HRN: 22-44-42 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/16/2024
CEFUROXIME 500MG (TAB)
05/16/2024
05/23/2024
ORAL
500mg/tab
BID
CAP LR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes